Back

The novel myosin activator, danicamtiv alters both systolic and diastolic functions in vitro and in vivo

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in basic science 2 Heart Failure HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Arnold Peter Raduly

University of Debrecen, Debrecen (Hungary)

7 More presentations in this session

Presentation thumbnail
DETECT-Heart: biomarkers for screening of patients referred to the cardiovascular outpatient clinic
Mr C. Geraeds (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
The predictive value of matrix metalloproteinase-9 as an inflammation marker in anticipating adverse events one year after experiencing a st-elevation myocardial infarction
Associate Professor I. Vyshnevska (Kharkiv, UA)
Abstract Slides Video
Presentation thumbnail
HFWM: evaluating the importance of myeloperoxidase in the early anticipation of subsequent chronic heart failure occurrences in individuals after st-segment elevation acute myocardial infarction
Associate Professor I. Vyshnevska (Kharkiv, UA)
Abstract Slides Video
Presentation thumbnail
MicroRNA-based network analysis identified the NOVA1 gene as a potential new target in end-stage heart failure
Miss T. Balint (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Novel insights in cardiac fibrosis in HFpEF: potential role of UBALD2-enriched endothelial extracellular vesicles
Miss B. Losada Fuentenebro (Pamplona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in basic science 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Temporal changes in echocardiographic parameters of diastolic dysfunction in obstructive hypertrophic cardiomyopathy during mavacamten treatment
thumbnail
Congress Presentation
Changes in hemodynamic, strain and myocardial work parameters predict long term mortaility and rehospitalization in acute, decompensated heart failure after levosimendan administration.
thumbnail
Congress Presentation
Effects of mavacamten on the cellular response to beta adrenergic and frequency dependent stress in an HFpEF mouse model

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources